A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Summary

This study adds an experimental treatment with another type of cells, called dendritic cells. It is hoped that these cells may stimulate the immune system to react against neuroblastoma in much the same way that vaccines cause the immune system to react to certain viruses and bacteria. The physicians conducting this study have observed from previous research that neuroblastoma cells can be recognized by the immune system, and that they can be destroyed by immune cells.The main goal of this study is to see if giving participants this additional anti-Neuroblastoma vaccine reduces the risk of relapse following the Hematopoietic Stem Cell Transplant.

Timeline

Start

2016-04-14

Primary completion

2017-08-21

Completion

2017-08-21

Outcome

Outcome not reported

Stopped (Enrollment): “no enrollment”

Drugs

Indications